We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

T cells.

Immune Cells “Remember” the Pain of Newborn Injuries

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

A scientist in a lab holding up a centrifuge tube.

Materials Follow the “Rule of Four” — But Scientists Don’t Know Why Yet

Neuro-Cognitive Computer Models Make Reading More Efficient

Promising Treatment Approach for Aggressive Leukemia Identified

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

News

Discussing the Science of Big DNA

Read about the most recent advances in synthetic biology in the latest issue of DECODED.

SBRI Healthcare Launches New Competitions, with £5 Million to Invest this Year

Funding will be awarded in a new round of competitions under the SBRI programme to develop innovative solutions towards better health outcomes.

Agilent Technologies to Separate into Two Public Companies

Life sciences, diagnostics and applied markets (LDA) that will retain the Agilent name, and the other company will be comprised of Agilent's electronic measurement (EM) products.

Epigenetic Regulation of ADME-Related Genes: Focus on Drug Metabolism and Transport

As research in epigenetic regulation of ADME genes progresses, there are many opportunities and challenges in understanding the epigenetic mechanisms in drug metabolism and disposition.

Cangene Receives Approval for WinRho

Company has received marketing authorization approval in Portugal from INFARMED.

Research Pilot Supported by Chemical Engineers

Pilot will help inform EPSRC’s strategy for chemical engineering.

Creabilis Announces Treatment of First Patients in its Phase 2b Trial of CT327

Phase 2b study of CT327 in patients with atopic dermatitis.

Radium Ra 223 Dichloride Recommended for Approval in EU

Approval of radium-223 for the treatment of castration-resistant prostate cancer with bone metastases.

Versatile Proteins Could be New Target for Alzheimer’s Drugs

NIH-funded discovery began with asking how the brain learns to see.

Two UK Companies Shortlisted for EuropaBio Most Innovative EU Biotech SME Award

e-Therapeutics and PsiOxus Therapeutics have received two year's free membership of EuropaBio.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter